151 related articles for article (PubMed ID: 38468509)
21. Practice, Knowledge, and Barriers for Screening of Hepatocellular Carcinoma Among High-Risk Chinese Patients.
Xu K; Watanabe-Galloway S; Rochling FA; Zhang J; Farazi PA; Peng H; Wang H; Luo J
Ann Glob Health; 2017; 83(2):281-292. PubMed ID: 28619403
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
23. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
Wun YT; Dickinson JA
Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
[TBL] [Abstract][Full Text] [Related]
25. Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Xu C; Wu F; Du L; Dong Y; Lin S
Front Immunol; 2023; 14():1211399. PubMed ID: 37809083
[TBL] [Abstract][Full Text] [Related]
26. Barriers and facilitators of colorectal cancer screening in Asia.
Hatamian S; Hadavandsiri F; Momenimovahed Z; Salehiniya H
Ecancermedicalscience; 2021; 15():1285. PubMed ID: 34824608
[TBL] [Abstract][Full Text] [Related]
27. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
Singal AG; Pillai A; Tiro J
PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
[TBL] [Abstract][Full Text] [Related]
28. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
29. Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.
Rich NE; Carr C; Yopp AC; Marrero JA; Singal AG
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e267-e288. PubMed ID: 33387668
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
Zhao C; Nguyen MH
J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
[TBL] [Abstract][Full Text] [Related]
31. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
[TBL] [Abstract][Full Text] [Related]
32. Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.
Hu DH; Yu SM
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):30-32. PubMed ID: 28886327
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
Cui K; Ou Y; Shen Y; Li S; Sun Z
Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
[TBL] [Abstract][Full Text] [Related]
34. Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis.
Wolf E; Rich NE; Marrero JA; Parikh ND; Singal AG
Hepatology; 2021 Feb; 73(2):713-725. PubMed ID: 32383272
[TBL] [Abstract][Full Text] [Related]
35. [Current global development of screening guidelines for hepatocellular carcinoma: a systematic review].
Yang JC; Yu SQ; Gao L; Zhou QX; Zhan SY; Sun F
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1126-1137. PubMed ID: 32741183
[No Abstract] [Full Text] [Related]
36. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.
Hu B; Tian X; Sun J; Meng X
Int J Mol Sci; 2013 Dec; 14(12):23559-80. PubMed ID: 24317431
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.
Xiong JJ; Altaf K; Javed MA; Huang W; Mukherjee R; Mai G; Sutton R; Liu XB; Hu WM
World J Gastroenterol; 2012 Dec; 18(45):6657-68. PubMed ID: 23236242
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
